Ray Reilly

Ray Reilly serves as the Vice President of Drug Development Operations at BioCryst Pharmaceuticals, Inc., a position held since October 2022. Previously, Ray held multiple leadership roles including Vice President of Clinical Operations at Aceragen and TG Therapeutics, as well as Vice President of Clinical Operations at IQVIA Biotech following Novella Clinical's transition to IQVIA. Ray's extensive experience in clinical operations spans over two decades, with notable positions in project management and clinical monitoring at Novella Clinical, Tranzyme Pharma, PharmaLinkFHI, ClinTrials, and Remington Davis. Ray earned a Bachelor of Science degree in Biology from the University of North Carolina at Chapel Hill.